JP6381628B2 - 生物試料の安定化 - Google Patents

生物試料の安定化 Download PDF

Info

Publication number
JP6381628B2
JP6381628B2 JP2016503571A JP2016503571A JP6381628B2 JP 6381628 B2 JP6381628 B2 JP 6381628B2 JP 2016503571 A JP2016503571 A JP 2016503571A JP 2016503571 A JP2016503571 A JP 2016503571A JP 6381628 B2 JP6381628 B2 JP 6381628B2
Authority
JP
Japan
Prior art keywords
sample
cell
nucleic acid
cells
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016503571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016514464A5 (cg-RX-API-DMAC7.html
JP2016514464A (ja
Inventor
ラルフ ヴュリヒ,
ラルフ ヴュリヒ,
トルステン フォス,
トルステン フォス,
カレ ギュンター,
カレ ギュンター,
ウーヴェ アールミューラー,
ウーヴェ アールミューラー,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiagen GmbH
Original Assignee
Qiagen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen GmbH filed Critical Qiagen GmbH
Publication of JP2016514464A publication Critical patent/JP2016514464A/ja
Publication of JP2016514464A5 publication Critical patent/JP2016514464A5/ja
Application granted granted Critical
Publication of JP6381628B2 publication Critical patent/JP6381628B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2016503571A 2013-03-18 2014-03-18 生物試料の安定化 Active JP6381628B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361803107P 2013-03-18 2013-03-18
US61/803,107 2013-03-18
EP13160896.0 2013-03-25
EP13160896 2013-03-25
EP13180130.0 2013-08-12
EP13180130 2013-08-12
PCT/EP2014/000725 WO2014146781A1 (en) 2013-03-18 2014-03-18 Stabilisation of biological samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018143839A Division JP6750178B2 (ja) 2013-03-18 2018-07-31 生物試料の安定化

Publications (3)

Publication Number Publication Date
JP2016514464A JP2016514464A (ja) 2016-05-23
JP2016514464A5 JP2016514464A5 (cg-RX-API-DMAC7.html) 2017-02-16
JP6381628B2 true JP6381628B2 (ja) 2018-08-29

Family

ID=51579331

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016503571A Active JP6381628B2 (ja) 2013-03-18 2014-03-18 生物試料の安定化
JP2018143839A Active JP6750178B2 (ja) 2013-03-18 2018-07-31 生物試料の安定化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018143839A Active JP6750178B2 (ja) 2013-03-18 2018-07-31 生物試料の安定化

Country Status (5)

Country Link
US (2) US11525155B2 (cg-RX-API-DMAC7.html)
EP (2) EP2976424B1 (cg-RX-API-DMAC7.html)
JP (2) JP6381628B2 (cg-RX-API-DMAC7.html)
CN (3) CN122405616A (cg-RX-API-DMAC7.html)
WO (1) WO2014146781A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012314514B2 (en) 2011-09-26 2018-03-15 Qiagen Gmbh Stabilisation and isolation of extracellular nucleic acids
WO2013045458A1 (en) 2011-09-26 2013-04-04 Preanalytix Gmbh Stabilisation and isolation of extracellular nucleic acids
CN113388605A (zh) 2011-09-26 2021-09-14 凯杰有限公司 用于分离细胞外核酸的快速方法
US11021733B2 (en) 2011-09-26 2021-06-01 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
JP6608280B2 (ja) 2012-09-25 2019-11-20 キアゲン ゲーエムベーハー 生物学的試料の安定化
US20160281133A1 (en) 2013-03-18 2016-09-29 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CA2940692C (en) 2014-03-18 2025-07-08 Qiagen Gmbh STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS
WO2016130543A1 (en) * 2015-02-09 2016-08-18 Abogen, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis
EP3885438A1 (en) 2015-06-10 2021-09-29 QIAGEN GmbH Method for isolating extracellular nucleic acids using anion exchange particles
JP7166169B2 (ja) 2015-11-20 2022-11-07 キアゲン ゲーエムベーハー 細胞外核酸の滅菌のための滅菌組成物を調製する方法
DK3205722T3 (en) * 2016-02-11 2018-11-26 Sarstedt Ag & Co Kg Device and methods for isolating nucleic acids from blood
AU2017269608C1 (en) 2016-05-27 2023-12-07 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
EP3358020B1 (en) 2017-01-05 2021-05-19 Biodesix, Inc. Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
WO2019126343A1 (en) * 2017-12-19 2019-06-27 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
EP3905881A1 (en) 2019-01-04 2021-11-10 QIAGEN GmbH Urine stabilization
CN114450402A (zh) 2019-09-24 2022-05-06 恰根有限公司 稳定化的含细胞体液样品的多模式分析
EP4477751A1 (en) 2023-06-16 2024-12-18 QIAGEN GmbH Body fluid stabilization and processing

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389133A (en) 1966-08-10 1968-06-18 Schwarz Biores Inc Process for isolating and purifying soluble ribonucleic acid
US3903179A (en) 1973-10-15 1975-09-02 Gulf Research Development Co Method for preparing nitrocyclopropane from 3-chloro-1-nitropropane
JPS6083581A (ja) * 1983-10-13 1985-05-11 Hideaki Yamada シユ−ドモナス属細菌の培養法
US4938961A (en) 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5460797A (en) 1991-05-08 1995-10-24 Streck Laboratories, Inc. Method for fixing tissues and cells for analysis using oxazolidine compounds
US5459073A (en) 1991-05-08 1995-10-17 Streck Laboratories, Inc. Method and composition for preserving antigens and process for utilizing cytological material produced by same
GB9215002D0 (en) * 1992-07-15 1992-08-26 Univ Singapore Method of fixing biological tissue
EP0743950B1 (de) 1994-02-11 2001-12-12 QIAGEN GmbH Verfahren zur trennung von doppelstrang/einzelstrangnukleinsäurestrukturen
ES2304782T3 (es) 1994-08-11 2008-10-16 Sanofi-Aventis Deutschland Gmbh Anticuerpos monoclonales para determinacion inmunologica selectiva de formas de lamininas de alto peso molecular, intactas en fluidos corporales.
US5705628A (en) 1994-09-20 1998-01-06 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles
US5817470A (en) 1995-03-10 1998-10-06 Sociedad Biotecnologica Collico Limitada Immobilization of antigens to solid support by the mussel adhesive polyphenolic protein and the method for use therein
US20050158699A1 (en) 1995-06-07 2005-07-21 Kadkade Prakash G. Cryopreservation of plant cells
US6673364B1 (en) 1995-06-07 2004-01-06 The University Of British Columbia Liposome having an exchangeable component
ATE284891T1 (de) 1996-02-14 2005-01-15 Biomerieux Bv Isolierung von einzelsträngigen nukleinsäuren
EP0929694A4 (en) 1996-03-15 2002-05-02 Penn State Res Found DETECTION OF TUMOR-RELATED EXTRACELLULAR NUCLEIC ACID USING PLASMA OR BLOOD SERUM USING NUCLEIC ACID AMPLIFICATION TESTS
CA2250118C (en) 1996-03-26 2009-09-29 Michael S. Kopreski Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
US5707812A (en) 1996-08-06 1998-01-13 Vical Incorporated Purification of plasmid DNA during column chromatography
AU5532498A (en) * 1996-12-27 1998-07-31 Sherwood Medical Company Anticoagulant composition
WO1998041651A1 (en) 1997-03-18 1998-09-24 Hsc Research & Development Limited Partnership Method for preparing chromatin
DE19726362A1 (de) 1997-06-21 1998-12-24 Schaeffler Waelzlager Ohg Vorrichtung zum Verändern der Steuerzeiten von Gaswechselventilen einer Brennkraftmaschine
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
WO1999058664A1 (en) 1998-05-14 1999-11-18 Whitehead Institute For Biomedical Research Solid phase technique for selectively isolating nucleic acids
JP4349545B2 (ja) 1998-06-17 2009-10-21 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Fy7ポリメラーゼ
DE19836559A1 (de) 1998-08-12 2000-03-23 Antigen Gmbh Gefäß zur Entnahme von Blut
US6407107B1 (en) 1999-05-28 2002-06-18 The Board Of Trustees Of The Unversity Of Arkansas Derivatives of butyric acid and uses thereof
US6379930B1 (en) 1999-07-30 2002-04-30 Applied Gene Technologies, Inc. Stabilization of nucleic acid amplification cocktails
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
DE10006662A1 (de) 2000-02-15 2001-08-23 Antigen Produktions Gmbh Gefäß zur Nukleinsäureanalytik
EP1762251A1 (en) 2000-03-23 2007-03-14 Clearant, Inc. Methods for sterilizing biological materials
WO2001079272A2 (en) * 2000-04-18 2001-10-25 Tularik Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use
DE10031236A1 (de) 2000-06-27 2002-01-10 Qiagen Gmbh Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien
US6602718B1 (en) 2000-11-08 2003-08-05 Becton, Dickinson And Company Method and device for collecting and stabilizing a biological sample
EP2090655B1 (en) 2001-02-16 2013-05-08 Promega Corporation Magnetic isolation and purification of nucleic acids
WO2003019141A2 (en) 2001-08-23 2003-03-06 Immunivest Corporation Analysis of circulating tumor cells, fragments, and debris
US20030064000A1 (en) 2001-09-24 2003-04-03 Wilson Burgess Methods of sterilizing biological mixtures using stabilizer mixtures
DE60230788D1 (de) 2001-11-06 2009-02-26 Cortex Biochem Inc Isolierung und aufreinigung von nukleinsäuren
US6954128B2 (en) 2001-11-30 2005-10-11 The Regents Of The University Of California High performance hybrid magnetic structure for biotechnology applications
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
AU2002367863A1 (en) 2002-04-10 2003-10-27 Clearant, Inc. Methods for sterilizing biological materials
US20040043505A1 (en) 2002-05-07 2004-03-04 Matthew Walenciak Collection assembly
US7442506B2 (en) 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
US20040054160A1 (en) * 2002-09-16 2004-03-18 Santona Pal Nucleic-acid ink compositions for arraying onto a solid support
US20060212020A1 (en) * 2002-10-10 2006-09-21 Lynne Rainen Sample collection system with caspase inhibitor
CN1720453A (zh) 2002-12-02 2006-01-11 东洋钢钣株式会社 将多聚核苷酸固定于固体支持物的方法 ,由此获得的固体固定化支持物 ,从固体支持物上检测目的多聚核苷酸的方法以及用于固定化多聚核苷酸的溶液
US20040167165A1 (en) 2003-01-16 2004-08-26 Geetha Shankar Methods of treating conditions associated with an Edg-7 receptor
US7601491B2 (en) * 2003-02-06 2009-10-13 Becton, Dickinson And Company Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
US8758974B2 (en) 2003-03-27 2014-06-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Photoresist-free micropatterning on polymer surfaces
US7250270B2 (en) 2003-06-13 2007-07-31 Ambion, Inc. Methods and compositions for preparing tissue samples for RNA extraction
EP1510577A1 (en) 2003-08-29 2005-03-02 Qiagen GmbH Method for magnetic bead isolation of nucleic acids
US20070208166A1 (en) 2003-10-24 2007-09-06 Exelixis, Inc. Tao Kinase Modulators And Method Of Use
US7270799B2 (en) 2004-01-15 2007-09-18 Nst Neurosurvival Technologies Ltd. Perturbed membrane-binding compounds and methods of using the same
KR20070004725A (ko) 2004-02-20 2007-01-09 더 리전츠 오브 더 유니버시티 오브 캘리포니아 타액 mRNA 프로파일링, 생물 마커 및 관련 방법 및부품 키트
US8426126B2 (en) 2004-03-18 2013-04-23 Applied Biosystems, Llc Modified surfaces as solid supports for nucleic acid purification
US20080176209A1 (en) 2004-04-08 2008-07-24 Biomatrica, Inc. Integration of sample storage and sample management for life science
EP2168975A3 (en) 2004-05-24 2012-01-11 Genvault Corporation Method of stably storing biomolecules in recoverable form
BRPI0513310A (pt) 2004-07-12 2008-05-06 Idun Pharmaceuticals Inc análogos de tetrapeptìdeo
US7727718B2 (en) 2005-01-04 2010-06-01 Molecular Research Center, Inc. Reagents for storage and preparation of samples for DNA analysis
EP1859038B1 (en) 2005-02-11 2010-08-04 Invitrogen Dynal AS Method for isolating nucleic acids comprising the use of ethylene glycol multimers
FR2883003B1 (fr) 2005-03-14 2008-04-11 Aldivia Sa Nouveaux antioxydants a base d'especes d'anacardiacees, plus particulierement de sclerocarya birrea, leurs procedes d'obtention et leurs applications
DE102005015005A1 (de) 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
AU2011253662A1 (en) 2005-11-30 2011-12-22 Massachusetts Institute Of Technology Pathogen-detecting cell preservation systems
EP1804045B1 (de) 2005-12-30 2014-03-12 QIAGEN GmbH Ein Verfahren und ein Kit zur Behandlung einer biologischen Probe
CA2635975A1 (en) * 2006-01-04 2007-07-12 Do-Coop Technologies Ltd. Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
AU2007207434B2 (en) 2006-01-20 2012-04-05 Reneuron, Inc. Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
US20070190535A1 (en) 2006-02-13 2007-08-16 Hall Gerald E Jr Size fractionation of nucleic acid samples
CA2550133A1 (en) 2006-02-16 2007-08-16 The Governors Of The University Of Alberta Temperature regulated gene expression
JP5274781B2 (ja) 2007-03-22 2013-08-28 昭和電工株式会社 R−t−b系合金及びr−t−b系合金の製造方法、r−t−b系希土類永久磁石用微粉、r−t−b系希土類永久磁石
US7828887B2 (en) 2007-04-23 2010-11-09 Hewlett-Packard Development Company, L.P. Dye-based ink formulations
DE102007025277A1 (de) * 2007-05-31 2008-12-04 Qiagen Gmbh Verfahren zur Stabilisierung einer biologischen Probe
US7892724B2 (en) 2007-07-12 2011-02-22 Warsaw Orthopedic, Inc Method for enhancing the viability of mammalian cells, tissues and organs using a solution comprising two low molecular weight PEGs
US7960098B2 (en) 2007-07-12 2011-06-14 Warsaw Orthoperic, Inc. Methods and compositions for the preservation of cells and tissues
EP2027922A1 (de) 2007-08-02 2009-02-25 Qiagen GmbH Verfahren und Vorrichtung für das Fixieren/Stabilisieren einer Probe
US20100285468A1 (en) * 2007-09-24 2010-11-11 Allelogic Biosciences Corporation Detection and/or quantification of nucleic acids
RU2496482C2 (ru) 2008-03-05 2013-10-27 Бакстер Интернэшнл Инк. Композиции и способы для доставки лекарственных средств
WO2010065420A2 (en) 2008-12-03 2010-06-10 Integrated Nano-Technologies, Inc. Universal biological sample processing
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
US8304187B2 (en) * 2009-02-18 2012-11-06 Streck, Inc. Preservation of cell-free RNA in blood samples
US20100280233A1 (en) 2009-05-04 2010-11-04 Connolly Dennis M Method for sample preparation
US20150056604A1 (en) 2009-06-15 2015-02-26 Biovec Transfusion, Llc Compositions and methods for preserving platelet function
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
US8222397B2 (en) 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
TWI407994B (zh) 2009-10-22 2013-09-11 Ind Tech Res Inst 分離核酸的方法、試劑及套組
AU2010311421B2 (en) 2009-10-29 2014-11-20 Ascendis Pharma A/S Sterilization of biodegradable hydrogels
DK2496720T3 (da) * 2009-11-06 2020-09-28 Univ Leland Stanford Junior Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter
US20110111410A1 (en) 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in intact cells within a blood sample
JP5773347B2 (ja) 2009-11-27 2015-09-02 国立大学法人 千葉大学 血液細胞の凍結保存剤
US8093427B2 (en) 2010-06-09 2012-01-10 National Tsing Hua University Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid
WO2011157678A1 (en) 2010-06-14 2011-12-22 Qiagen Gmbh Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples
FR2964567B1 (fr) 2010-09-14 2013-03-15 Lvmh Rech Extrait d'orchidee
EP2704719B1 (en) 2011-05-03 2018-02-21 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
US9664702B2 (en) * 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US11021733B2 (en) * 2011-09-26 2021-06-01 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
WO2013045458A1 (en) 2011-09-26 2013-04-04 Preanalytix Gmbh Stabilisation and isolation of extracellular nucleic acids
AU2012314514B2 (en) * 2011-09-26 2018-03-15 Qiagen Gmbh Stabilisation and isolation of extracellular nucleic acids
US20140243216A1 (en) 2011-09-26 2014-08-28 Qiagen Gmbh Methods for separating nucleic acids by size
CN113388605A (zh) 2011-09-26 2021-09-14 凯杰有限公司 用于分离细胞外核酸的快速方法
EP3663408B1 (en) 2011-10-11 2024-05-01 QIAGEN GmbH Sample processing method and sample processing cartridge
IL287381B2 (en) 2011-11-14 2024-04-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human rpe cells and uses thereof
US9546358B2 (en) 2012-06-04 2017-01-17 New England Biolabs, Inc. Compositions and methods for reducing background DNA amplification
JP6608280B2 (ja) 2012-09-25 2019-11-20 キアゲン ゲーエムベーハー 生物学的試料の安定化
WO2014055936A1 (en) 2012-10-04 2014-04-10 Integenx Inc. Preservation of biological materials in non-aqueous fluid media
GB201303666D0 (en) 2013-03-01 2013-04-17 Goldsborough Andrew S Sample fixation and stabilisation
US20160281133A1 (en) 2013-03-18 2016-09-29 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CA2940692C (en) 2014-03-18 2025-07-08 Qiagen Gmbh STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS
JP6687601B2 (ja) 2014-08-07 2020-04-22 ザ ジェネラル ホスピタル コーポレイション 全血サンプルの安定化

Also Published As

Publication number Publication date
CN122405616A (zh) 2026-07-17
JP6750178B2 (ja) 2020-09-02
US11525155B2 (en) 2022-12-13
US20160348151A1 (en) 2016-12-01
EP2976424B1 (en) 2018-10-03
JP2018166519A (ja) 2018-11-01
CN105283550A (zh) 2016-01-27
US20220364149A1 (en) 2022-11-17
CN122465910A (zh) 2026-07-28
WO2014146781A1 (en) 2014-09-25
EP3447141B1 (en) 2020-08-05
EP2976424A1 (en) 2016-01-27
JP2016514464A (ja) 2016-05-23
EP3447141A1 (en) 2019-02-27

Similar Documents

Publication Publication Date Title
JP6750178B2 (ja) 生物試料の安定化
JP6608280B2 (ja) 生物学的試料の安定化
AU2019200643B2 (en) Stabilization and isolation of extracellular nucleic acids
JP6407248B2 (ja) 細胞外核酸の安定化および単離
AU2012314514B2 (en) Stabilisation and isolation of extracellular nucleic acids
JP6155269B2 (ja) 細胞外核酸の安定化および単離
JP7548904B2 (ja) 尿安定化
JP2019136044A (ja) 細胞外核酸の安定化および単離

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180418

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180703

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180731

R150 Certificate of patent or registration of utility model

Ref document number: 6381628

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250